FstSNP-HapMap3: a database of SNPs with high population differentiation for HapMap3 by Duan, Shiwei et al.
Bioinformation by Biomedical Informatics Publishing Group                                    open access 
www.bioinformation.net                                                                       Database 
______________________________________________________________________________ 
 
ΙSSN 0973-2063 (online) 0973-2063 (print)                                                                             
Bioinformation 3(3): 139-141 (2008) 
Bioinformation, an open access forum 
© 2008 Biomedical Informatics Publishing Group 
 
139
 
FstSNP-HapMap3: a database of SNPs with high 
population differentiation for HapMap3 
 
 
Shiwei Duan
1, Wei Zhang
1, Nancy Jean Cox
1, 2 and Mary Eileen Dolan
1, 3, 4, * 
 
1Section of Hematology/Oncology, Department of Medicine; 
2Department of Human Genetics; 
3Committee on Clinical Pharmacology and 
Pharmacogenomics; 
4Cancer Research Center, The University of Chicago, IL 60637, USA; M. Eileen Dolan* - Email: 
edolan@medicine.bsd.uchicago.edu; Phone: 773 702 4441; Fax: 773 702 0963; * Corresponding author 
 
received September 16, 2008; revised October 10; accepted October 15, 2008; published November 09, 2008 
 
Abstract: 
The International HapMap Project has recently made available genotypes and frequency data for phase 3 (NCBI build 36, dbSNP 
b129) of the HapMap providing an enriched genotype dataset for approximately 1.6 million single nucleotide polymorphisms 
(SNPs) from 1,115 individuals with ancestry from parts of Africa, Asia, Europe, North America and Mexico. In the present 
study, we aim to facilitate pharmacogenetics studies by providing a database of SNPs with high population differentiation 
through a genomewide test on allele frequency variation among 11 HapMap3 samples. Common SNPs with minor allele 
frequency greater than 5% from each of 11 HapMap3 samples were included in the present analysis. The population 
differentiation is measured in terms of fixation index (Fst), and the SNPs with Fst values over 0.5 were defined as highly 
differentiated SNPs. Our tests were carried out between all pairs of the 11 HapMap3 samples or among subgroups with the same 
continental ancestries. Altogether we carried out 64 genomewide Fst tests and identified 28,215 highly differentiated SNPs for 49 
different combinations of HapMap3 samples in the current database. 
 
Availability: http://FstSNP-hapmap3.googlecode.com/ 
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Background: 
With a public dataset of both genotypes and inferred 
haplotypes for millions of SNPs in ethnically diverse 
samples, the International HapMap Project [1] has provided a 
landscape of the human genome that enables genetic 
scientists to compare their genetic variant results with that of 
a reference. The vast information from the International 
HapMap Project has significantly driven the development of 
more efficient statistical tools for high-throughput analysis of 
large genetic data sets [2] and enhanced our knowledge of 
population genetics [3-4]. Given that the HapMap samples 
are Epstein-Barr virus (EBV)-transformed lymphoblastoid 
cell lines (LCLs) that can be purchased [5], researchers can 
perform integrated analysis that includes genetic variation, 
gene expression [6-9], gene transcript isoforms [10] and 
sensitivity to drugs [11-15].  
 
HapMap3 enhances the initial HapMap samples with 1,115 
individual samples collected from 11 populations around the 
world, thus providing more diversity. The HapMap3 includes 
samples from individuals of African, Asian, European and 
Mexican descent residing in various locations. Therefore, it 
has become an ideal resource to study genotype-phenotype 
relationships with cellular phenotypes. 
 
In this analysis, we compare the genotypic frequencies of 
over 1 million SNPs among the samples. We hypothesize that 
the list of candidate SNPs, which have significantly different 
allele frequency distributions among the diverse samples, 
will facilitate studies attempting to correlate genotype with 
cellular phenotypes such as pharmacogenomics, and alert 
investigators to SNPs that might contribute 
disproportionately to substructure within more heterogeneous 
samples. 
 
Methodology: 
HapMap3 genotypic data and SNP function classes 
The genotypic data of 1,115 individuals from 11 population 
samples were downloaded from the International HapMap 
Project website (Phase III, release 1). Two samples 
NA18955, NA18962 in the CHB group actually belong to the 
JPT sample set, and thus were dropped out of the analysis. In 
the current study, the tested population panel focused only on  
the 931 unrelated individuals comprised of Gujarati Indians 
in Houston, Texas (GIH, n = 83), individuals of Mexican 
ancestry in Los Angeles, California (MEX, n = 47) and 
individuals of  African ancestry from the Southwest USA 
(ASW, n = 47), Luhya in Webuye, Kenya (LWK, n = 83), 
Maasai in Kinyawa, Kenya (MKK, n = 143), Yoruba in 
Ibadan, Nigeria (YRI, n = 108), Han Chinese from Beijing, Bioinformation by Biomedical Informatics Publishing Group                                    open access 
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China (CHB, n = 80), Chinese from metropolitan Denver, 
Colorado (CHD, n = 70), Japanese from Tokyo, Japan (JPT, 
n= 82); Utah residents with Northern and Western European 
ancestry from the CEPH collection (CEU, n = 111), and 
Tuscans from Italy (TSI, n = 77). Of note, two samples 
(NA18955, NA18962) included in the CHB group belong to 
JPT. Five groups of samples (ASW, CEU, MEX, MKK and 
YRI) are familial samples; and the rest are unrelated samples. 
A total of 1,614,792 polymorphic SNPs were genotyped in 
the HapMap3 Project. The number of shared SNPs ranges 
from 1,047,055 to 1,487,361 for the pair-wise combinations 
of the 11 HapMap3 population samples (Fig.1). Using the 
same reference allele of a SNP, we calculated the allele 
frequencies across all the populations. 
 
 
Figure 1:  The diagram for the construction of FstSNP_HapMap3. 
 
Fst calculation 
Fst, a metric representation of the effect of population 
subdivision, was estimated according to Wright’s 
approximate formula,  where  H T S T H H H Fst / ) ( − = T 
represents expected heterozygosity per locus of the total 
population and HS represents expected heterozygosity of a 
subpopulation [16]. An Fst value was calculated for each 
SNP of interest with allele frequencies estimated from the 
unrelated individuals in each population. We calculated Fst 
values for only SNPs with minor allele frequencies greater 
than 5% in each of the HapMap3 samples. 
 
Dataset 
The dataset [17] contains all SNPs with Fst value over 0.5 
from the tests between any two of the 11 HapMap3 samples. 
There are 28,215 common SNPs with high population 
differentiation observed for at least 1 of 49 different 
combinations of HapMap3 population samples in the 
databases.  
 
Development 
The genotypes of approximately 1.6 million SNPs were 
downloaded from the International HapMap Project 
(HapMap3, release 1). Fst was evaluated for over 1 million 
SNPs for each of the 55 paired combinations from the 11 
HapMap3 samples, followed by rearrangement into five 
distinct groups defined by historical geographic ancestry 
(African, Asian, European, MEX and GIH) (Fig.1). The Fst 
test was evaluated again among the combinations of the five 
geographical defined groups. Altogether there are 64 Bioinformation by Biomedical Informatics Publishing Group                                    open access 
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genomewide Fst tests for the HapMap3 samples. SNPs with 
high population differentiation (Fst > 0.5) were categorized 
into two major classes: genic and nongenic SNPs. The genic 
SNPs were further divided into six function classes including 
intron, UTR (utr-3 or utr-5), locus region (near-gene-3 or 
near-gene-5), splice site, coding synonymous or 
nonsynonymous based on the annotation in the NCBI 
dbSNP129 database. The SNP annotation was added as a 
separate column to facilitate additional applications in the 
future. 
 
Database content 
This database [17] provides 115, 212 entries of 28,215 SNPs 
with high differentiation among 48 different combinations of 
the HapMap3 samples. There are six columns for the 
database as follows: SNP, SNP_CHR (SNP Chromosome), 
SNP_POSI (SNP position in dbSNP129), Fst value, 
Tested_Populations and DbSNP129_Class. The number of 
the entries in each group ranges from 3 for GIH_TSI group to 
10,416 for JPT_YRI group. 
 
Database usage 
The users can download the FstSNP_HapMap3 [17] and then 
query the database by the conditions of genomic regions or a 
list of SNPs or SNP Class.  
 
Caveats: 
The Fst test was evaluated in the HapMap3 population 
samples, some of which have relatively small sample size 
(e.g. 47 individuals in ASW and MEX).  Furthermore, we 
note that SNPs included in HapMap3 are subject to a number 
of ascertainment biases; thus, these SNPs cannot be 
considered as representative of Fst values that might be 
calculated for all common variants. 
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